Page last updated: 2024-11-05

2,2',2''-trichlorotriethylamine and Diffuse Large B-Cell Lymphoma

2,2',2''-trichlorotriethylamine has been researched along with Diffuse Large B-Cell Lymphoma in 1 studies

2,2',2''-trichlorotriethylamine: RN given refers to parent cpd; structure

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Klener, P1
Donner, L1

Other Studies

1 other study available for 2,2',2''-trichlorotriethylamine and Diffuse Large B-Cell Lymphoma

ArticleYear
Trichlortriethylamine (TS-160 Spofa) in combination chemotherapy of malignant lymphomas.
    Neoplasma, 1975, Volume: 22, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymp

1975